1. Home
  2. RMBS vs JAZZ Comparison

RMBS vs JAZZ Comparison

Compare RMBS & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMBS
  • JAZZ
  • Stock Information
  • Founded
  • RMBS 1990
  • JAZZ 2003
  • Country
  • RMBS United States
  • JAZZ Ireland
  • Employees
  • RMBS N/A
  • JAZZ N/A
  • Industry
  • RMBS Semiconductors
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMBS Technology
  • JAZZ Health Care
  • Exchange
  • RMBS Nasdaq
  • JAZZ Nasdaq
  • Market Cap
  • RMBS 7.8B
  • JAZZ 6.7B
  • IPO Year
  • RMBS 1997
  • JAZZ 2007
  • Fundamental
  • Price
  • RMBS $73.79
  • JAZZ $113.20
  • Analyst Decision
  • RMBS Strong Buy
  • JAZZ Strong Buy
  • Analyst Count
  • RMBS 5
  • JAZZ 12
  • Target Price
  • RMBS $80.60
  • JAZZ $183.00
  • AVG Volume (30 Days)
  • RMBS 1.4M
  • JAZZ 628.2K
  • Earning Date
  • RMBS 07-28-2025
  • JAZZ 08-05-2025
  • Dividend Yield
  • RMBS N/A
  • JAZZ N/A
  • EPS Growth
  • RMBS 0.94
  • JAZZ 49.21
  • EPS
  • RMBS 2.11
  • JAZZ 7.51
  • Revenue
  • RMBS $645,488,000.00
  • JAZZ $4,064,808,000.00
  • Revenue This Year
  • RMBS $26.64
  • JAZZ $6.10
  • Revenue Next Year
  • RMBS $12.99
  • JAZZ $5.07
  • P/E Ratio
  • RMBS $34.94
  • JAZZ $15.07
  • Revenue Growth
  • RMBS 35.17
  • JAZZ 5.76
  • 52 Week Low
  • RMBS $37.43
  • JAZZ $95.49
  • 52 Week High
  • RMBS $76.20
  • JAZZ $148.06
  • Technical
  • Relative Strength Index (RSI)
  • RMBS 63.57
  • JAZZ 48.58
  • Support Level
  • RMBS $69.51
  • JAZZ $112.17
  • Resistance Level
  • RMBS $76.07
  • JAZZ $117.39
  • Average True Range (ATR)
  • RMBS 2.89
  • JAZZ 2.77
  • MACD
  • RMBS 0.61
  • JAZZ -0.33
  • Stochastic Oscillator
  • RMBS 82.00
  • JAZZ 24.15

About RMBS Rambus Inc.

Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: